Perioral dermatitis - I-Perioral Dermatitis
https://en.wikipedia.org/wiki/Perioral_dermatitis
☆ Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine. 

Papules azungeze umlomo nasemakhaleni anobubomvu obuthile bangemuva avame ukubonwa njengepheshana noma i-pustule emlonyeni.
relevance score : -100.0%
References
Perioral Dermatitis 30247843 NIH
I- Perioral dermatitis yisimo sesikhumba esibucayi esivame ukubonakala kwabesifazane abasebasha, esibonakala ngamaqhubu amancane abomvu noma amabala esikhumba esomile, esinamaxolo emlonyeni. Nakuba ngokuvamile ithinta indawo ezungeze umlomo, ingase ivele eduze kwamehlo nekhala, okuholela esiteketisoni sayo, i-periorificial dermatitis. Ukusetshenziswa kwe-topical steroids ebusweni kungabangela lesi simo, ngakho-ke isinyathelo sokuqala sokwelashwa ngokuvamile simisa ukusetshenziswa kwalezi zidakamizwa. Ezinye izindlela zokwelapha zihlanganisa ukusebenzisa i-topical metronidazole noma i-calcineurin inhibitors, noma ukuphuza ama-antibiotic e-tetracycline. I-Perioral dermatitis ivame ukusabela kahle ekwelashweni, kodwa ngezinye izikhathi ingaphikelela noma ibuye ngokuphindaphindiwe.
Perioral dermatitis is a benign eruption that occurs most commonly in young, female adults, consisting of small inflammatory papules and pustules or pink, scaly patches around the mouth. Although the perioral region is the most common area of distribution, this disease also can affect the periocular and paranasal skin. For this reason, it is often referred to as periorificial dermatitis. Topical steroid use to the face can trigger this, and therefore, a primary recommendation for treatment would be discontinuation of steroid application by the patient. Other treatment approaches include topical metronidazole, topical calcineurin inhibitors, and oral tetracycline antibiotics. Perioral dermatitis often responds readily to therapy but can be chronic and recurrent.
Allergic contact cheilitis caused by propolis: case report 35195191 NIH
I-Propolis iyi-lipophilic substance ekhishwe ezitshalweni yizinyosi. Inhloso yalo mbiko wecala bekuwukukhombisa ukubaluleka kwalesi sidakamizwa njengembangela ye-allergic contact cheilitis. Isiguli sesifazane esineminyaka engu-21 ubudala sakhononda nge-pruritic perioral eczema iminyaka engu-5. Ezinyangeni ezedlule iphinde yathinta intamo. Ngemva kokuhlonza i-contact dermatitis, wahanjiswa ekuhlolweni kwe-patch. Umphumela wokuhlolwa kwe-patch wawuvuma ngokuqinile i-propolis (++) .
Propolis is a lipophilic resin extracted from plants by bees. The purpose of this case report was to show the importance of this substance as cause of allergic contact cheilitis. A 21-year-old female patient complained of pruritic perioral eczema for 5 years. In the past months it also affected the neck. After diagnosing contact dermatitis, she was submitted to a patch test with a Latin American baseline series. The result was strongly positive for propolis (++)
Predictive Model for Differential Diagnosis of Inflammatory Papular Dermatoses of the Face 33911757 NIH
Izifo ezihlukahlukene zesikhumba ezivuthayo ezibonakala ngama-erythematous papules. Isifo esivamile emtholampilo - folliculitis, rosacea ; Isifo esingavamile uma kuqhathaniswa - eosinophilic pustular folliculitis (EPF) , granulomatous periorificial dermatitis (GPD) , lupus miliaris disseminatus faciei (LMDF) .
Various inflammatory skin diseases characterized by erythematous papules that most often affect the face include clinically common folliculitis and rosacea, and relatively rare eosinophilic pustular folliculitis (EPF), granulomatous periorificial dermatitis (GPD), and lupus miliaris disseminatus faciei (LMDF).
Ama-topical steroid angaba yimbangela yalesi simo futhi izinto zokuthambisa nezimonyo nazo zingaba nomthelela ekukhuleni kwesifo sesikhumba. Ukwelashwa ngokuvamile ngokumisa ama-topical steroids nezimonyo, futhi ezimeni ezinzima kakhulu, ukuthatha i-tetracyclines ngomlomo. Ukumisa ama-steroid kungase kuqale kube kubi kakhulu ukuqubuka.
Lesi simo silinganiselwa ukuthi sithinta u-0.5-1% wabantu ngonyaka emazweni athuthukile. Bafika ku-90% abathintekayo ngabesifazane abaneminyaka ephakathi kuka-16 no-45.
○ Ukwelashwa - Izidakamizwa ze-OTC
I-Perioral dermatitis ivame ukubangelwa yi-chronic contact dermatitis yezimonyo, ngakho-ke ukusebenzisa izimonyo emlonyeni akukhuthazwa. Ukuthatha i-OTC antihistamine kungase kube usizo. Ukwelashwa ngokuvamile kwakudingeka ezinyangeni ezimbalwa.
#OTC antihistamine